Canada Biotechnology & Medical Research

Hemostemix Inc (HEM)

Track

Track

Hemostemix Inc. recorded two insider trading transactions over the past ninety days, both involving purchases. Directors Loran Lavern Swanberg and Peter Alan Lacey acquired shares totaling 200,000 CAD. These activities occurred ahead of the next scheduled results financiers, amidst an 18.2% stock price increase observed during this period.
Ticker: HEM Exchange: CVE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Hemostemix Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.1
Swanberg, Loran Lavern Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
211.37
Quantity 51,333 -31.2%
Value CA$3,022,004
2.5
Lacey, Peter Alan Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
156.33
Quantity 83,167 +14.7%
Value CA$66,666
2.1
Swanberg, Loran Lavern Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
70.70
Quantity 45,981 +37.7%
Value CA$2,186,757
2.1
Swanberg, Loran Lavern Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.06
Quantity 26,500 +0.5%
Value CA$1,524
2.1
Swanberg, Loran Lavern Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.06
Quantity 20,000 +11.1%
Value CA$1,200
2.1
Swanberg, Loran Lavern Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.06
Quantity 1,265,000 +28.7%
Value CA$69,575
2.1
Swanberg, Loran Lavern Director of Issuer Non-Executive Director
Transaction date
Sale
Price
0.06
Quantity 1,265,000 -87.5%
Value CA$69,575
2.1
Swanberg, Loran Lavern Director of Issuer Non-Executive Director
Transaction date
Sale
Price
0.09
Quantity 1,265,000 -71.7%
Value CA$113,850
2.1
Swanberg, Loran Lavern Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.09
Quantity 1,265,000 +702.8%
Value CA$113,850
1.5
Smeenk, Thomas Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.09
Quantity 20,000 +0.3%
Value CA$1,700
Swanberg, Loran Director of Issuer Non-Executive Director
Transaction date
Planned purchase
Price
0.11
Quantity 1,000,000 +102.3%
Value CA$110,000
Swanberg, Loran Director of Issuer Non-Executive Director
Transaction date
Planned purchase
Price
0.11
Quantity 1,500,000 +59.8%
Value CA$165,000
Swanberg, Loran Director of Issuer Non-Executive Director
Transaction date
Planned purchase
Price
0.11
Quantity 500,000 +57.8%
Value CA$55,000
2.5
Lacey, Peter Alan Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.08
Quantity 260,000 +1.2%
Value CA$19,500
2.5
Lacey, Peter Alan Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.08
Quantity 200,000 +0.9%
Value CA$15,000
2.5
Lacey, Peter Alan Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.08
Quantity 400,000 +1.9%
Value CA$30,000
1.5
Smeenk, Thomas Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.12
Quantity 200,000 +5.1%
Value CA$23,000
2.1
Swanberg, Loran Lavern Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.10
Quantity 400,000 +15.9%
Value CA$40,000
2.1
Swanberg, Loran Lavern Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.10
Quantity 400,000 +46.2%
Value CA$40,000
2.5
Lacey, Peter Alan Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.10
Quantity 15,000,000 +254.2%
Value CA$1,500,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-10 2026-06-26 B Purchase
2.1
Swanberg, Loran Lavern

Director of Issuer

Non-Executive Director
51,333 -31.2%
211.37
CA$3,022,004 		51,333 -31.2% 211.37 CA$3,022,004
2026-06-28 2026-06-25 B Purchase
2.5
Lacey, Peter Alan

Director of Issuer

Non-Executive Director
83,167 +14.7%
156.33
CA$66,666 		83,167 +14.7% 156.33 CA$66,666
2026-08-10 2026-06-10 B Purchase
2.1
Swanberg, Loran Lavern

Director of Issuer

Non-Executive Director
45,981 +37.7%
70.70
CA$2,186,757 		45,981 +37.7% 70.70 CA$2,186,757
2026-08-10 2026-06-10 B Purchase
2.1
Swanberg, Loran Lavern

Director of Issuer

Non-Executive Director
26,500 +0.5%
0.06
CA$1,524 		26,500 +0.5% 0.06 CA$1,524
2026-08-10 2026-06-10 B Purchase
2.1
Swanberg, Loran Lavern

Director of Issuer

Non-Executive Director
20,000 +11.1%
0.06
CA$1,200 		20,000 +11.1% 0.06 CA$1,200
2026-08-10 2026-05-20 B Purchase
2.1
Swanberg, Loran Lavern

Director of Issuer

Non-Executive Director
1,265,000 +28.7%
0.06
CA$69,575 		1,265,000 +28.7% 0.06 CA$69,575
2026-08-10 2026-05-20 S Sale
2.1
Swanberg, Loran Lavern

Director of Issuer

Non-Executive Director
1,265,000 -87.5%
0.06
CA$69,575 		1,265,000 -87.5% 0.06 CA$69,575
2026-08-10 2026-02-09 S Sale
2.1
Swanberg, Loran Lavern

Director of Issuer

Non-Executive Director
1,265,000 -71.7%
0.09
CA$113,850 		1,265,000 -71.7% 0.09 CA$113,850
2026-08-10 2026-02-09 B Purchase
2.1
Swanberg, Loran Lavern

Director of Issuer

Non-Executive Director
1,265,000 +702.8%
0.09
CA$113,850 		1,265,000 +702.8% 0.09 CA$113,850
2025-12-16 2025-12-16 B Purchase
1.5
Smeenk, Thomas

Director of Issuer

Non-Executive Director
20,000 +0.3%
0.09
CA$1,700 		20,000 +0.3% 0.09 CA$1,700
2025-11-04 2025-11-03 PP Planned purchase
Swanberg, Loran

Director of Issuer

Non-Executive Director
1,000,000 +102.3%
0.11
CA$110,000 		1,000,000 +102.3% 0.11 CA$110,000
2025-11-04 2025-11-03 PP Planned purchase
Swanberg, Loran

Director of Issuer

Non-Executive Director
1,500,000 +59.8%
0.11
CA$165,000 		1,500,000 +59.8% 0.11 CA$165,000
2025-11-04 2025-11-03 PP Planned purchase
Swanberg, Loran

Director of Issuer

Non-Executive Director
500,000 +57.8%
0.11
CA$55,000 		500,000 +57.8% 0.11 CA$55,000
2025-08-19 2025-08-18 B Purchase
2.5
Lacey, Peter Alan

Director of Issuer

Non-Executive Director
260,000 +1.2%
0.08
CA$19,500 		260,000 +1.2% 0.08 CA$19,500
2025-08-13 2025-08-11 B Purchase
2.5
Lacey, Peter Alan

Director of Issuer

Non-Executive Director
200,000 +0.9%
0.08
CA$15,000 		200,000 +0.9% 0.08 CA$15,000
2025-08-13 2025-08-08 B Purchase
2.5
Lacey, Peter Alan

Director of Issuer

Non-Executive Director
400,000 +1.9%
0.08
CA$30,000 		400,000 +1.9% 0.08 CA$30,000
2025-08-06 2025-08-05 B Purchase
1.5
Smeenk, Thomas

Director of Issuer

Non-Executive Director
200,000 +5.1%
0.12
CA$23,000 		200,000 +5.1% 0.12 CA$23,000
2026-08-10 2025-07-23 B Purchase
2.1
Swanberg, Loran Lavern

Director of Issuer

Non-Executive Director
400,000 +15.9%
0.10
CA$40,000 		400,000 +15.9% 0.10 CA$40,000
2026-08-10 2025-07-23 B Purchase
2.1
Swanberg, Loran Lavern

Director of Issuer

Non-Executive Director
400,000 +46.2%
0.10
CA$40,000 		400,000 +46.2% 0.10 CA$40,000
2025-07-25 2025-07-23 B Purchase
2.5
Lacey, Peter Alan

Director of Issuer

Non-Executive Director
15,000,000 +254.2%
0.10
CA$1,500,000 		15,000,000 +254.2% 0.10 CA$1,500,000
Explore more

More insider trading research around Hemostemix Inc

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America